Cardiovascular/Heart
Show Only Open Trials
1.
Optimization of A-V and V-V Delay in CRT with surface Electrocardiogram and Impedance Cardiography compared to Echocardiography
- Study Status: Open to Enrollment
- Sponsor: New York Cardiac Center & Michael Wolk Heart Foundation
2.
Surescan Pacing System Post-Approval Study
- Study Status: Open to Enrollment
- Sponsor: Medtronic
3.
Late Sodium Current Blockade in High Risk ICD Patients, Ranolazine ICD Trial (RAID)
- Study Status: Open to Enrollment
- Sponsor: NIH
4.
Evaluation of Exercise Treadmill test indices in patients with cardiovascular disease
- Study Status: Open to Enrollment
- Sponsor: Novartis
- Disease Status and/or Stage: Stable Coronary Artery Disease
5.
Utility of Adenosine in Assessing Pulmonary Vein Reconnection After Pulmonary Vein Isolation-Atrial Fibrillation Study
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College Department of Medicine/Division of Cardiology
6.
A Study of the Evalve Cardiovascular Valve Repair System (CVRS)Endovascular Valve Edge-to-Edge REpair Study II (EVEREST II) Protocol # 401 Continued Access Registry
- Study Status: Open to Enrollment
- Sponsor: Evalve, Inc.
7.
Heart Failure and Pulmonary Hypertension Registry
- Study Status: Open to Enrollment
8.
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study of Cicletanine in Subjects with Pulmonary Arterial Hypertension
- Study Status: Open to Enrollment
- Sponsor: Gilead Sciences
9.
The Natural History and Outcome of Scleroderma Patients at High Risk or with Early Pulmonary Hypertension
- Study Status: Open to Enrollment
- Sponsor: Georgetown University
10.
Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)
- Study Status: Open to Enrollment
- Sponsor: NIH/NIMHD
11.
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS)
- Study Status: Open to Enrollment
- Sponsor: National Heart, Lung and Blood Institute (NHLBI)
12.
ATHENA-1: An Open-Label, Multicenter Study of Ambrisentan and Phosphodiesterase Type-5 Inhibitor Combination Therapy in Subjects with Pulmonary Arterial Hypertension Who Have Demonstrated a Suboptimal Response to Phosphodiesterase Type-5 Inhibitor
- Study Status: Closed to Enrollment
- Sponsor: Gilead Sciences
13.
Cytokine Levels in Hypertensive and Normotensive Individuals
- Study Status: Closed to Enrollment
14.
Rapid Switch from Intravenous Epoprostenol to Intravenous Remodulin (Treprostinil Sodium) Using the Crono Five Ambulatory Infusion Pump in Patients with Stable Pulmonary Arterial Hypertension: Safety, Efficacy and Treatment Satisfaction
- Study Status: Open to Enrollment
- Sponsor: United Therapeutics
15.
Sympathetic Nerve Stimulation in Patients with Right Ventricular Outflow Tract Tachycardia
- Study Status: Open to Enrollment
- Sponsor: WCMC Department of Medicine
16.
Cardiac Electrophysiology Laboratory Database Information Acquisition
- Study Status: Open to Enrollment
- Sponsor: WCMC Department of Medicine
17.
Adaptive Cardiac Resynchronization Therapy (aCRT)
- Study Status: Closed to Enrollment
- Sponsor: Medtronic
18.
Closure of Atrial Septal Defects with the Amplatzer Septal Occluder Post-Approval Study
- Study Status: Open to Enrollment
- Sponsor: AGA Medical Corporation
